|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Watanabe SI, Nakagawa K, Suzuki K,
Takamochi K, Ito H, Okami J, Aokage K, Saji H, Yoshioka H, Zenke Y,
et al: Neoadjuvant and adjuvant therapy for stage III non-small
cell lung cancer. Jpn J Clin Oncol. 47:1112–1118. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
hou Q, Huang SX, Zhang F, Li SJ, Liu C, Xi
YY, Wang L, Wang X, He QQ, Sun CC, et al: MicroRNAs: A novel
potential biomarker for diagnosis and therapy in patients with
non-small cell lung cancer. Cell Prolif. 50:2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Khandelwal A, Seam RK, Gupta M, Rana MK,
Prakash H, Vasquez KM and Jain A: Circulating microRNA-590-5p acts
as a liquid biopsy marker in non-small cell lung cancer. Cancer
Sci. 111:826–839. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Qu Y and Zhang N: MiR-365b-3p inhibits the
cell proliferation and migration of human coronary artery smooth
muscle cells by directly targeting ADAMTS1 in coronary
atherosclerosis. Exp Ther Med. 16:4239–4245. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang J, Wang X, Wu G, Hou D and Hu Q:
MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle
progression and apoptosis of human retinoblastoma cells by
targeting PAX6. FEBS Lett. 587:1779–1786. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tian Q, Sun HF, Wang WJ, Li Q, Ding J and
Di W: MiRNA-365b promotes hepatocellular carcinoma cell migration
and invasion by downregulating SGTB. Future Oncol. 15:2019–2028.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Niang B, Jin L, Chen X, Guo X, Zhang H, Wu
Q, Padhiar AA, Xiao M, Fang D and Zhang J: Galnac-t4 putatively
modulates the estrogen regulatory network through FOXA1
glycosylation in human breast cancer cells. Mol Cell Biochem.
411:393–402. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sahasrabudhe NM, Lenos K, van der Horst
JC, Rodríguez E and van Vliet SJ: Oncogenic BRAFV600E drives
expression of MGL ligands in the colorectal cancer cell line HT29
through N-acetylgalactosamine-transferase 3. Biol Chem.
399:649–659. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Detarya M, Sawanyawisuth K, Aphivatanasiri
C, Chuangchaiya S, Saranaruk P, Sukprasert L, Silsirivanit A, Araki
N, Wongkham S and Wongkham C: The O-GalNAcylating enzyme GALNT5
mediates carcinogenesis and progression of cholangiocarcinoma via
activation of AKT/ERK signaling. Glycobiology: Dec 4, 2019 (Epub
ahead of print).
|
|
13
|
erois N, Gattolliat CH, Barrios E,
Capandeguy L, Douc-Rasy S, Valteau-Couanet D, Bénard J and Osinaga
E: GALNT9 gene expression is a prognostic marker in neuroblastoma
patients. Clin Chem. 59:225–233. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Weng L, Ma J, Jia YP, Wu SQ, Liu BY, Cao
Y, Yin X, Shang MY and Mao AW: MiR-4262 promotes cell apoptosis and
inhibits proliferation of colon cancer cells: Involvement of
GALNT4. Am J Transl Res. 10:3969–3977. 2018.PubMed/NCBI
|
|
15
|
Qu JJ, Qu XY and Zhou DZ: MiR-4262
inhibits colon cancer cell proliferation via targeting of GALNT4.
Mol Med Rep. 16:3731–3736. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42 (Database Issue):D92–D97. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Li WQ, Zhang JP, Wang YY, Li XZ and Sun L:
MicroRNA-422a functions as a tumor suppressor in non-small cell
lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Cell Cycle. 18:1727–1744. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li ZY, Zhang ZZ, Bi H, Zhang QD, Zhang SJ,
Zhou L, Zhu XQ and Zhou J: Upregulated microRNA-671-3p promotes
tumor progression by suppressing forkhead box P2 expression in
non-small-cell lung cancer. Mol Med Rep. 20:3149–3159.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yu G, Li S, Liu P, Shi Y, Liu Y, Yang Z,
Fan Z and Zhu W: LncRNA TUG1 functions as a ceRNA for miR-6321 to
promote endothelial progenitor cell migration and differentiation.
Exp Cell Res. 338(111839)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Deng G, Mou T, He J, Chen D, Lv D, Liu H,
Yu J, Wang S and Li G: Circular RNA circRHOBTB3 acts as a sponge
for miR-654-3p inhibiting gastric cancer growth. J Exp Clin Cancer
Res. 39(1)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kim H, Burassakarn A, Kang Y, Iizasa H and
Yoshiyama H: A single nucleotide polymorphism in the BART promoter
region of Epstein-Barr virus isolated from nasopharyngeal cancer
cells. Biochem Biophys Res Commun. 520:373–378. 2019.PubMed/NCBI View Article : Google Scholar
|
